It is a pharma private limited company based in Rohini, Delhi, India, established in 2002.
2002 | Rohini, Delhi, India | ActiveResearch Medicine Private Limited, a active private limited company, was established on 27 September 2002 in Rohini, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239DL2002PTC117163. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹2.00 Cr.
Formerly known as Srishti Pharmaceuticals Private Limited. It upholds a compliant status. Its leadership includes Manoj Kalra (Director), Chander Mohan (Director), Rajesh Sharma (Additional Director). It holds ₹2.12 Cr open charges and ₹1.31 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at A-306, Phase-1 Vijay Vihar, Rohini, Delhi, 110085.
U24239DL2002PTC117163
117163
27 September 2002
₹2.00 Cr
₹2.00 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Research Medicine Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manoj Kalra | Director | 27 Sep 2002 | Current |
| Chander Mohan | Director | 27 Sep 2002 | Current |
| Rajesh Sharma | Additional Director | 17 Jun 2025 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Research Medicine Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 35.84% decrease. The company also saw a substantial fall in profitability, with a 21.88% decrease in profit. The company's net worth Soared by an impressive increase of 59.2%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Research Medicine had a promoter holding of 180.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹21,172,000.00
₹13,100,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Jan 2025 | Others | ₹0.47 M | Open |
| 08 Nov 2021 | Canara Bank | ₹1.20 M | Open |
| 26 Jul 2016 | Canara Bank | ₹1.95 Cr | Open |
| 16 Jan 2013 | Bank Of Baroda | ₹8.10 M | Satisfied |
| 03 Feb 2004 | Union Bank Of India | ₹5.00 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Research Medicine, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Research Medicine, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Research Medicine's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Rajesh Sharma was appointed as a Additional Director was appointed as a Additional Director on 17 Jun 2025 & has been associated with this company since 5 months 17 days . was recorded as a recent event.
The activity A charge with Others amounted to Rs. 0.05 Cr with Charge ID 101064603 was registered on 08 Jan 2025. was completed.
Progress on Research Medicine Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Research Medicine Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
A charge with Canara Bank amounted to Rs. 0.12 Cr with Charge ID 100508684 was registered on 08 Nov 2021. was recorded as a recent event.
A charge with Canara Bank of Rs. 1.95 Cr registered on 26 Jul 2016 with Charge ID 100046215 was modified on 26 Jun 2021. was recorded as a recent event.
The CIN of Research Medicine Private Limited is U24239DL2002PTC117163.
Research Medicine Private Limited is headquartered at A-306, Phase-1 Vijay Vihar, Rohini, Delhi, 110085.
Research Medicine Private Limited was incorporated on 27 September 2002.
The current directors of Research Medicine Private Limited are
The primary industry of Research Medicine Private Limited is Manufacturing.
Research Medicine Private Limited is unlisted.
The authorized capital of Research Medicine Private Limited is ₹2.00 Cr, and the paid-up capital is ₹2.00 Cr.
The compliance status of Research Medicine Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX